Unknown

Dataset Information

0

Design and evaluation of novel glutaminase inhibitors.


ABSTRACT: A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-butyl moiety present in the leading inhibitors by heteroatom substituted heterocycloalkanes.

SUBMITTER: McDermott LA 

PROVIDER: S-EPMC6300166 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5846160 | BioStudies
2017-01-01 | S-EPMC5391743 | BioStudies
2016-01-01 | S-EPMC5295402 | BioStudies
| S-EPMC6070111 | BioStudies
2020-01-01 | S-EPMC7333265 | BioStudies
2016-01-01 | S-EPMC5340236 | BioStudies
2019-01-01 | S-EPMC6889173 | BioStudies
2019-01-01 | S-EPMC6579458 | BioStudies
2019-01-01 | S-EPMC6518522 | BioStudies
2018-01-01 | S-EPMC5815916 | BioStudies